Related Experiment Video
Updated: Jun 23, 2026

Detection of Toxin Translocation into the Host Cytosol by Surface Plasmon Resonance
Published on: January 3, 2012
A receptor decoy inhibits the enterotoxic effects of Clostridium difficile toxin A in rat ileum
I Castagliuolo1, J T LaMont, B Qiu
1Division of Gastroenterology, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Background & Aims:
Clostridium difficile toxin A causes secretion and intestinal inflammation in rodents by binding to a specific trisaccharide Gal alpha 1-3Gal beta 1-4 GlcNAc on enterocyte receptors. The purpose of this study was to explore the ability of Synsorb 90 (Synsorb Biotech Inc., Calgary, Alberta, Canada), and inert support carrying this trisaccharide, to bind toxin A in vitro and to inhibit its enterotoxic effects in vivo.
Methods:
Binding of [3H]toxin A to Synsorb 90, Synsorb 83 (beta-mannose attached), and Chromosorb P (inert support with no sugar attached) (Synsorb Biotech Inc.) was measured. The inhibitory effects of these compounds on toxin A-mediated fluid secretion, mannitol permeability, and histological damage were measured in ileal loops in vivo.
Results:
Toxin A showed specific binding to Synsorb 90, bearing the specific trisaccharide that binds toxin A, but not to Synsorb 83 or to Chromosorb P. Pretreatment of rats with Synsorb 90 by gavage (200 mg/kg body wt), but no Synsorb 83 or Chromosorb P at the same doses, dramatically reduced toxin A-associated fluid secretion and permeability.
Conclusions:
An immobilized toxin A receptor sequesters toxin A in the intestinal lumen and inhibits its effects of ileal mucosa. These results suggest a potential use for this agent in treating patients with C. difficile colitis.
Insights
Synsorb 90, which carries a specific trisaccharide that binds Clostridium difficile toxin A, effectively sequesters the toxin in the gut. This prevents toxin A-induced intestinal fluid secretion and inflammation, suggesting its therapeutic potential for C. difficile colitis.
Area of Science:
- Gastroenterology
- Microbiology
- Biotechnology
Background:
- Clostridium difficile toxin A induces intestinal secretion and inflammation by binding to a specific trisaccharide on enterocyte receptors.
- This trisaccharide is Gal alpha 1-3Gal beta 1-4 GlcNAc.
Purpose of the Study:
- To evaluate Synsorb 90, an inert support with the trisaccharide, for its ability to bind toxin A in vitro.
- To assess Synsorb 90's efficacy in inhibiting toxin A's enterotoxic effects in vivo.
Main Methods:
- Binding assays were performed using radiolabeled toxin A and Synsorb 90, Synsorb 83 (beta-mannose), and Chromosorb P (inert control).
- In vivo studies utilized rat ileal loops to measure toxin A-mediated fluid secretion, mannitol permeability, and histological damage after treatment with the compounds.
Main Results:
- Synsorb 90 demonstrated specific binding to toxin A, unlike Synsorb 83 and Chromosorb P.
- Oral administration of Synsorb 90 significantly reduced toxin A-induced fluid secretion and increased intestinal permeability in rats.
Conclusions:
- An immobilized toxin A receptor, such as Synsorb 90, can sequester toxin A in the intestinal lumen, thereby inhibiting its detrimental effects on the ileal mucosa.
- These findings indicate a potential therapeutic application for Synsorb 90 in managing Clostridium difficile colitis.
More Related Videos
Related Concept Videos
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Bacterial Toxins
Botulism

